Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Incretin-based inpatient hyperglycemia treatment study
MOH_2017-08-23_000651Phase 4Not yet recruiting
- Sponsor
- מיכה רפפורט
- Start
- Aug 2017
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of liraglutide, linagliptin, insulin glargine and human insulin in hyperglycemia and diabetes mellitus (DM) (3 arms), sponsored by מיכה רפפורט. Planned start Aug 2017; status: not yet recruiting.
02
Drugs
03
Conditions
hyperglycemiadiabetes mellitus (DM)
Beyond the preview
Go deeper on MOH_2017-08-23_000651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2017-08-23_000651.